The effects of quercetin on SW480 human colon carcinoma cells: a proteomic study by Mouat, Michael F et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
Nutrition Journal
Open Access Research
The effects of quercetin on SW480 human colon carcinoma cells: a 
proteomic study
Michael F Mouat1, Kumar Kolli2, Ronald Orlando2, James L Hargrove1 and 
Arthur Grider*1
Address: 1Department of Foods and Nutrition, University of Georgia, Athens, Georgia 30602, USA and 2Complex Carbohydrate Research Center, 
University of Georgia, Athens, Georgia 30602, USA
Email: Michael F Mouat - mmouat@fcs.uga.edu; Kumar Kolli - kumar@ccrc.uga.edu; Ronald Orlando - orlando@ccrc.uga.edu; 
James L Hargrove - jhargrov@fcs.uga.edu; Arthur Grider* - agrider@fcs.uga.edu
* Corresponding author    
Abstract
Background: High fruit and vegetable intake is known to reduce the risk of colon cancer. To
improve understanding of this phenomenon the action of different phytochemicals on colon cells
has been examined. One such compound is quercetin that belongs to the group known as
flavonoids. The purpose of this study was to determine the influence of quercetin on the proteome
of the SW480 human colon adenocarcinoma cell line, specifically to identify proteins that could be
the molecular targets of quercetin in its amelioration of the progression of colon cancer. To this
end, two-dimensional gel electrophoresis and mass spectrometry were used to identify proteins
that underwent a change in expression following treatment of the cells with 20 µM quercetin. This
could elucidate how quercetin may reduce the progression of colon cancer.
Results: Quercetin treatment of the SW480 human colon cancer cells was found to result in the
decreased expression of three proteins and the increased expression of one protein. The identified
proteins with decreased expression were type II cytoskeletal 8 keratin and NADH dehydrogenase
Fe-S protein 3. The other protein with decreased expression was not identified. The protein with
increased expression belonged to the annexin family.
Conclusion: Several proteins were determined to have altered expression following treatment
with quercetin. Such changes in the levels of these particular proteins could underlie the chemo-
protective action of quercetin towards colon cancer.
Background
Colorectal cancer is the third most common cancer diag-
nosed both in men and in women in the United States [1].
The American Cancer Society estimates that 104,950 new
cases of colon cancer (48,290 men and 56,660 women)
and 40,340 new cases of rectal cancer (23,530 men and
16,810 women) will be diagnosed in 2005 [1]. It is esti-
mated that in the United States colorectal cancer will
cause about 10% of all cancer-related deaths during 2005
with 56,290 deaths (28,540 men and 27,750 women) [1].
For 1998–2000 the lifetime probability of men in the
United States developing cancer of the colon and rectum
was 1 in 17; for women it was 1 in 18 [2].
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Genetic factors account for only 10% of colorectal cancers
[3,4] and thus environmental factors must also be
involved in colon cancer development. Up to 80% of all
colorectal cancer cases and deaths are attributable to diet
[5] and such cases of colorectal cancer and related deaths
may be prevented by dietary modifications [6]. Studies
have suggested that a diet with an increased intake of fruit
and vegetables correlates with a reduced risk of colorectal
cancer [7,8]. For this, the chemical components of plants
known as phytochemicals may be crucially involved [9].
Particular phytochemicals characterized by their phenolic
ring structures are termed polyphenols and the most
abundant and widely distributed of these are the flavo-
noids. Quercetin is the most widely distributed flavonoid
found in foods, and is most abundant in apples, onions,
black tea and red wine [10]. Studies in vitro and in vivo
have suggested that quercetin may have a protective role
against breast [11], lung [12], liver [13], ovarian [14] and
colon [15-17] cancers.
Knowledge of how quercetin protects against cancer in
general and colorectal cancer in particular could be gained
by examining how quercetin affects the proteome of
colon cancer cells. Specifically, the influence of quercetin
on protein expression in the SW480 colon adenocarci-
noma cell line could be instructive in elucidating the
mechanisms underlying the protective role of the flavo-
noid against colon cancer. This would strengthen the sci-
entific evidence for advocating a diet rich in fruit and
vegetables to decrease the risk of developing colon cancer.
Moreover, an identification of those proteins affected by
quercetin could enhance understanding of the roles of
these proteins in colon neoplasia. Use of proteomic tech-
niques was therefore adopted in this study to determine
the influence of quercetin treatment on protein expres-
sion in SW480 colon cancer cells. Quercetin treatment
was found to result consistently in the decreased expres-
sion of three proteins and the increased expression of one
protein. All, except one of the down-expressed proteins,
were identified by mass spectrometry. Thus protein targets
that could be the molecular basis of inhibition of colon
cancer by quercetin were obtained.
Methods
Cell culture
SW480 human colon carcinoma cells (ATCC, Rockville,
MD) were grown in Leibovitz's L-15 medium with 2 mM
L-glutamine (ATCC, Rockville, MD), supplemented with
10% fetal bovine serum (Equitech-Bio Inc., Kerrville, TX).
Cells were maintained in 75 cm2 canted-neck flasks in 15
ml medium and incubated at 37°C without CO2. They
were subcultured once per week at a ratio of 1:4.
Quercetin treatment
When cells were about 90% confluent at seven days after
passage the medium was discarded and replaced with
medium containing 20 µM quercetin (Sigma, St. Louis
MO). Cells were incubated for 48 h in the quercetin-con-
taining medium at 37°C in air.
Isolation of protein
Following incubation of the cells in quercetin for 48 h the
medium was discarded and the cells washed three times
for 1 min each time with phosphate-buffered saline. After
complete removal of the final wash buffer, to each culture
flask was added 240 µl boiling sample buffer I (0.3%
sodium dodecyl sulfate (SDS), 200 mM dithiothreitol
(DTT), 50 mM Tris-HCl, pH 8.0). The lysed cells were
scraped together using a cell scraper (Fisher, Pittsburgh
PA). The lysate from each culture flask was transferred to
a 1.5 ml microfuge tube and heated for 5 min at 100°C.
After chilling the tube on ice 24 µl (1/10 volume) of sam-
ple buffer II (50 mM magnesium chloride, 0.1% DNAse I,
0.025% RNAse A, 0.5 M Tris-HCl, pH 8.0) was added.
Acetone was added to 80% (v/v) and the tube incubated
on ice for 20 min. After centrifugation at 12,000 rpm for
10 min the supernatant was discarded and the pellet
resuspended in 240 µl freshly prepared immobilized pH
gradient (IPG) sample buffer (7 M urea, 2 M thiourea, 4%
CHAPS, 1% DTT and 2% pH 3–10 ampholytes). The pro-
tein concentrations of the suspensions were measured
using the method of Bradford with Bio-Rad reagent and
bovine plasma gamma globulin as standard (Bio-Rad,
Hercules, CA).
Immobilized pH gradient electrophoresis
As the first dimension of two-dimensional electrophoresis
Bio-Rad pH 3–10 immobilized pH gradient (IPG) strips
were used to separate the cell proteins according to their
isoelectric points. A volume of the cell protein solution
containing 2 mg protein was mixed with rehydration
buffer (6 M urea, 2 M thiourea, 2% CHAPS, 0.4% DTT and
0.5% pH 3–10 ampholytes) for a final volume of 300 µl
per IPG gel. The IPG strips were loaded with the protein
sample and the strips passively rehydrated for 16 h. Isoe-
lectric focusing of the strips was at 250 V for 15 min fol-
lowed by rapid ramping to10,000 V for 3 h and
maintenance at the peak voltage for another 60,000 Vh.
Current was limited to 50 µA per gel.
Second dimension slab gel
The IPG strips were equilibrated with 6 M urea, 30% glyc-
erol, 2% SDS, 1.55 M Tris, 2 mM tributylphosphine (TBP)
and 0.00125% bromophenol blue (BPB) for 25 min with
shaking at room temperature. The strips were rinsed in
cathode buffer and applied to the top of 12% acrylamide
slab gels. The cathode buffer contained 50 mM Tris, 384
mM glycine and 6.9 mM SDS. Low-melting point agaroseNutrition Journal 2005, 4:11 http://www.nutritionj.com/content/4/1/11
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(1% in cathode buffer) was layered over the strips. The
anode buffer contained 25 mM Tris, 192 mM glycine and
3.5 mM SDS. The buffers were chilled to 4°C prior to use.
A cooling plate maintained the system (Genomic Solu-
tions, Ann Arbor, MI) at low temperature. The gels (22 cm
× 22 cm × 1 mm) were run at 20 W per gel until the BPB
dye front had migrated to within 1 cm from the bottom of
the gel. The gels were stained with Coomassie blue.
Quantification of protein spots
Second dimension gels were analyzed by Phoretix soft-
ware (Nonlinear Dynamics, Newcastle, UK). Comparison
between gels was achieved using normalized spot vol-
umes. To begin with, differences greater or equal to 1.5-
fold were considered to be significant. If these differences
were subsequently reproduced in additional experiments,
despite possibly being of lower magnitude, they were held
to be consistent.
Mass spectrometry
Differentially expressed protein spots were excised from
the gels and digested with trypsin as reported previously
[18]. Each gel plug was incubated with 150 µl of 50 mM
ammonium bicarbonate containing 12.2 M acetonitrile.
The gels were then dried and rehydrated with 5 µl of 50
mM ammonium bicarbonate containing 0.5 µg trypsin.
This solution was added in 5 µl aliquots until the gel piece
regained its original size. The gel was then covered with 50
mM ammonium bicarbonate and incubated overnight at
30°C. After the addition of 1.5 µl of 880 mM trifluoroace-
tic acid the peptides were extracted with 50 mM ammo-
nium bicarbonate containing 14.6 M acetonitrile. The
supernatants were dried to approximately 10 µl. The sam-
ples were each mixed with MALDI matrix solution pre-
pared as 5 mg/ml α -cyano-4-hydroxycinnamic acid in a
solution containing 1:1:1 acetonitrile, ethanol and 0.1%
trifluoroacetic acid (pH 2.0). Each mixture was spotted on
a MALDI target and allowed to air-dry. Peptide masses
were then obtained by MALDI-TOF MS (Applied Biosys-
tems 4700 Proteomics Analyzer). Calibration was per-
formed with the same procedure using mixtures of
peptides with known molecular masses.
MS/MS ions produced by MALDI-TOF from the tryptic
peptides and the results of a Mascot search http://
www.matrixscience.com/ were used to determine protein
identification. The NCBInr database, i.e. the non-identical
nr protein database of the National Center for Biotechnol-
ogy Information, was utilized for the search.
Results
Two-dimensional gel electrophoresis
Fig. 1 demonstrates a gel obtained from two-dimensional
gel electrophoresis of protein extracted from SW480 cells.
More than 500 protein spots could be observed. The gels
obtained from two-dimensional gel electrophoresis of
quercetin-treated and untreated (control) SW480 cell pro-
teins were compared (Fig. 2). Two mg protein was loaded
in each case. Four proteins were revealed to have under-
gone a consistent change in expression following treat-
ment with 20 µM quercetin for 48 h. Three proteins had a
decreased and one protein an increased expression. The
changes in these particular proteins were consistent
between four separate experiments, i.e. four separate quer-
cetin treatments coupled in each case with an untreated
control. Two experiments were run concurrently and then
another two on a different occasion. The proteins with
altered expression following quercetin treatment, consist-
ent between different experiments, are labeled 1–4 in Fig.
2. With observation solely by eye some of the differences
may not be readily apparent, but they were verified by
analysis of the gels using Phoretix 2-D analysis software
(Table 1). The results in Table 1 are the means from anal-
ysis of the gels from two separate experiments conducted
concurrently. In parentheses are the means from a second
set of two experiments run concurrently at a different time
to the first two experiments. The variation between the
two sets of results can be attributed to the cells having
been subcultured several times between the first and sec-
ond sets of experiments. Furthermore, the cells could have
been in a stage of growth for the second set of experiments
different from that for the first. Despite these sources of
variation, a consistent effect of quercetin in all four exper-
iments was searched for. From these results proteins 1, 2
and 4 each had decreased expression following quercetin
treatment of the cells. Protein 3 had increased expression.
Mass spectrometry
The protein spots that were differentially expressed fol-
lowing quercetin treatment were excised from the gels and
digested with trypsin. The tryptic digests were subjected to
matrix-assisted laser desorption and ionization-time of
flight (MALDI-TOF) mass spectrometry. The spectra were
analyzed and the data entered into appropriate databases
to identify the proteins. Table 2 lists the protein identities
together with their functions. Protein number 1 could not
be identified. Due to its proximity on the 2-D gels to pro-
tein number 2, i.e. type II cytoskeletal 8 keratin, it is pos-
sible that it is the same protein, but differing in its
modification. It is known that this keratin is phosphor-
ylated on serine residues; a process which is enhanced
during epidermal growth factor stimulation and mitosis.
Discussion
Four proteins were found to have their expression consist-
ently altered on quercetin treatment of SW480 colon car-
cinoma cells. Three of these proteins were down-regulated
and one was up regulated following exposure to querce-
tin. Using mass spectrometry three of the proteins were
identified. Those that were down-regulated were type IINutrition Journal 2005, 4:11 http://www.nutritionj.com/content/4/1/11
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cytoskeletal 8 keratin and NADH dehydrogenase (ubiqui-
none) Fe-S protein 3. The up-regulated protein belonged
to the annexin family.
Type II cytoskeletal 8 keratin (keratin 8) in another pro-
teomic study has been found to have a significantly lower
abundance in the normal mucosa compared with the
adjacent colon tumor for one specific patient for two out
of three gel protein features identified as keratin 8 [19].
For the same patient, keratins 18 and 19 also had signifi-
cantly lower concentrations in the normal mucosa com-
pared with the adjacent tumor. Similarly, with paired
samples of normal colon mucosa and adenocarcinomas
derived from 27 patients, proteomic analysis revealed that
keratin 18 was at a significantly lower level in the normal
mucosa compared with the tumor tissue [20]. In these
respects down regulation of keratin 8 by quercetin treat-
ment of SW480 cells would be akin to the cells becoming
more "normal", i.e. less tumorigenic. Further support for
this contention derives from analysis using the cDNA
macroarray technique of the differential gene expression
in isolated human colorectal cancer and respective nor-
mal mucosa from two patients [21]. The tumors showed
up-regulation of expression of type II cytoskeletal 8 kera-
tin and other angiogenesis-related genes to over 5-fold the
levels in normal mucosa. In the present study the down-
regulation of type II cytoskeletal 8 keratin by quercetin
may therefore demonstrate the decreased potential for
angiogenesis and hence reduction of any tumor.
Further support for the reduction in expression of type II
cytoskeletal 8 keratin following quercetin treatment of
SW480 colon cancer cells being reflective of decreased
neoplasia is derived from a proteomic analysis of lung
adenocarcinomas [22]. Cytoskeletal 8 keratin, in addition
to other keratins, had reduced expression in normal lung
samples compared with lung adenocarcinomas. Further-
more, several isoforms of cytoskeletal 8 keratin were iden-
tified. These had differing pI, but similar molecular
weights, and apparently result from differing extents of
Two-dimensional gel of protein from SW480 colon adeno- carcinoma cells Figure 1
Two-dimensional gel of protein from SW480 colon 
adenocarcinoma cells. SW480 cells were cultured as 
described in Methods. In this representative case the cells 
were not treated with quercetin and were thus a control. 
Cells were harvested; protein was extracted and subjected 
to two-dimensional electrophoresis as described in Meth-
ods. The gel was stained with Coomassie blue. The protein 
spots indicated were those subsequently determined to be 
significant in the effects of quercetin.
Two-dimensional gels of protein from control and quercetin- treated cells Figure 2
Two-dimensional gels of protein from control and 
quercetin-treated cells. After 7 days in culture SW480 
cells were incubated for 48 h in medium containing A. 0.2% 
dimethylsulfoxide (DMSO), since DMSO was the vehicle in 
which stock quercetin had been dissolved, and B. 20 µM 
quercetin and 0.2% dimethylsulfoxide (DMSO). Cells were 
harvested, protein extracted and subjected to two-dimen-
sional electrophoresis as described in Methods. The gels 
represent protein obtained from the control and quercetin-
treated cells of one of four separate treatment groups. 
Treatment was identical for each group. The indicated pro-
tein spots differed in levels consistently for each of these 
treatment groups.Nutrition Journal 2005, 4:11 http://www.nutritionj.com/content/4/1/11
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posttranslational phosphorylation [22]. This supports our
contention that unidentified protein 1 in the present
study may be an isoform of type II cytoskeletal 8 keratin.
A crucial role for this keratin in the malignant phenotype
is suggested by studies on its increased expression by
transfecting stratified epithelial cells with the cytoskeletal
8 keratin gene [23] and the epidermal consequences for
transgenic mice expressing the human keratin 8 [24]. In
each case neoplastic transformation of the cells to the
malignant phenotype occurred.
NADH dehydrogenase (ubiquinone) Fe-S protein 3 is a
component of complex 1 of the mitochondrial electron
transport chain. It is involved in transfer of electrons from
NADH to ubiquinone in the respiratory chain. A similar
component of complex 1 of the respiratory chain, NADH-
ubiquinone oxidoreductase, has been determined from a
proteomic analysis to be present in colon tumor tissue
and the surrounding normal mucosa [19]. Interestingly,
its abundance was higher in the tumor than in the normal
mucosa. This suggests that the lower level of NADH dehy-
drogenase (ubiquinone) Fe-S protein 3 in our quercetin-
treated colon cancer cells compared with its level in the
untreated cells is linked to a decreased tumorigenicity of
the cells following quercetin treatment. Furthermore,
NADH dehydrogenase (ubiquinone) has also been deter-
mined by others to have a decreased abundance in HT-29
human colon cancer cells following exposure for 24 h to
150 µM quercetin [25]. This supports what we determined
for NADH dehydrogenase (ubiquinone) Fe-S protein 3.
The implication is that the consequent reduction in
oxidative phosphorylation of substrates by quercetin is
associated with decreased tumorigenicity.
Following quercetin treatment, the only protein to be up-
regulated belonged to the annexin family. In another pro-
teomic study annexins I, III, IV and V have been deter-
mined to have a greater abundance in normal mucosa
compared with neighboring tumor tissue [19]. Thus the
rendering of the SW480 colon cancer cells less
tumorigenic by treatment with quercetin could be
reflected by the increased abundance of members of the
annexin family. To strengthen this argument the level of
annexin II, a protein that inhibits cell migration, was
found to increase in HT-29 human colon cancer cells fol-
lowing treatment with quercetin for 24 h and 48 h [25].
Inhibiting the ability of the cells to migrate would contrib-
ute to explaining the anti-cancer activity of quercetin. In
addition, annexin I, which promotes apoptotic cell
engulfment, increased in HT-29 cells exposed to quercetin
for 48 h. A role for apoptosis was also suggested when
annexin IV, a key regulator of apoptosis, was found to
Table 1: Effect of quercetin treatment of SW480 cells on the volume of protein spots on 2-D gels. The 2-D gels of protein from the 
untreated (control) and quercetin-treated SW480 cells were analyzed with Phoretix software. Normalized spot volumes were 
computed, averaged for two separate experiments run concurrently, and compared between the control and quercetin-treated gels. 
The 2-D gels obtained from one of the experiments are presented in Fig. 2. Results are the means, from the two experiments, for 
protein spots that differed in volume consistently in these two experiments and a subsequent two experiments. Alongside these 
results in parentheses are the mean results from the second set of two experiments.
Protein spot number Control volume Quercetin volume Increase/Decrease Fold change
1 6.61 (1.65) 2.89 (1.35) Decrease -2.29 (-1.22)
2 5.91 (4.18) 2.06 (3.26) Decrease -2.87 (-1.28)
3 0.118 (0.036) 0.243 (0.108) Increase +2.06 (+3.00)
4 0.411 (0.102) 0.088 (nd) Decrease -4.67 (-high)
Table 2: Proteins differentially expressed following quercetin treatment of SW480 cells. Protein spots determined to be present at 
different levels on gels following quercetin treatment of the SW480 cells were excised from the gels, digested with trypsin and 
subjected to MALDI-TOF mass spectrometry as described in Methods. From the mass spectra the identities of the proteins were 
determined using the appropriate databases.
Number from gel Protein Function
2 Keratin, type II cytoskeletal 8 Cytoskeletal structure, angiogenesis-related
3 Annexin family Ca2+ and phospholipid binding, regulation of exocytic and endocytic pathways
4 NADH dehydrogenase (ubiquinone) Fe-S 
protein 3
Transfer of electrons from NADH to the respiratory chainNutrition Journal 2005, 4:11 http://www.nutritionj.com/content/4/1/11
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increase in NCOL-1 human preneoplastic colonocytes fol-
lowing treatment with quercetin for 24 h [26]. Apoptosis,
mediated by members of the annexin family, may there-
fore also underlie the anti-cancer activity of quercetin.
Conclusion
Three proteins have been identified as potential molecular
targets for the proposed action against colon cancer of
quercetin the plant flavonoid. The application of pro-
teomic techniques demonstrated the response of these
proteins to quercetin treatment of colon cancer cells.
Other research in the field supported the response of each
of these proteins to quercetin. This serves to validate the
previous work. Furthermore, the responses could be
rationally described in terms of an anti-cancer action. This
strengthens earlier findings of quercetin's protection
against colon cancer using cell culture and animal models.
A basis is thus provided for further research with quercetin
and perhaps even advancement to studies with humans.
An intriguing aspect to consider is whether quercetin
could form the basis of directed drug design to yield drugs
with greater efficacy against the identified molecular tar-
gets and thereby provide an effective treatment of colon
cancer.
List of abbreviations used
NADH, nicotinamide adenine dinucleotide, reduced;
MALDI-TOF, matrix-assisted laser desorption and ioniza-
tion-time of flight;
MS, mass spectrometry
2-D, two-dimensional;
SDS, sodium dodecyl sulfate;
DTT, dithiothreitol;
IPG, immobilized pH gradient;
CHAPS, 3-[(3-cholamidopropyl) dimethylammonio]-1-
propane-sulfonate;
TBP, tributylphosphine;
BPB, bromophenol blue;
DMSO, dimethylsulfoxide;
NCBI, National Center for Biotechnology Information.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
MFM treated the cells, performed the two-dimensional
electrophoresis and gel analysis, submitted protein spots
for mass spectrometry, undertook the literature search on
the identified proteins, drafted the manuscript, submitted
the manuscript and completed all the necessary revisions
to make it acceptable for publication. KK carried out
trypsin digestion of the protein spots and undertook the
mass spectrometry. RO provided oversight for the mass
spectrometry. JLH and AG participated in conception and
design of the study. All the authors read and approved the
final manuscript.
Acknowledgements
We express our gratitude to Elizabeth Buck and Joan G Fischer for cultur-
ing the SW480 cells and providing them to us. Funding was from the Agri-
cultural Experiment Station, Hatch Project Number GEO00922.
References
1. American Cancer Society: Cancer Facts and Figures 2005 Atlanta,
American Cancer Society Inc; 2005. 
2. American Cancer Society: Cancer Statistics 2004 Atlanta, American
Cancer Society Inc; 2004. 
3. Armstrong F, Mathers JC: Kill and cure: dietary augmentation of
immune defences against colon cancer.  Proc Nutr Soc 2000,
59:215-220.
4. Go VLW, Wong DA, Butrum R: Diet, nutrition, and cancer pre-
vention: where are we going from here?  J Nutr 2001,
131:3121S-3126S.
5. Bingham S: Diet and colorectal cancer prevention. Biochem Soc
Trans 2000, 28:12-16.
6. Giovannucci E, Willett WC: Dietary factors and risk of colon
cancer. Ann Med 1994, 26:443-452.
7. Steinmetz K, Potter JD: Vegetables, fruit, and cancer preven-
tion: a review. J Amer Diet Assoc 1996, 96:1027-1039.
8. Fund WCR: Food, nutrition, and the prevention of cancer: a global
perspective Washington DC, American Institute for Cancer Research;
1997. 
9. Bloch A: Position of the American Dietetic Association: phy-
tochemicals and functional foods.  J Amer Diet Assoc 1995,
95:493-496.
10. Hollman PC, van Trijp JM, Mengelers MJ, de Vries JH, Katan MB: Bio-
availability of the dietary antioxidant flavonol quercetin in
man. Cancer Lett 1997, 114:139-140.
11. Choi JA, Kim JY, Lee JY, Kang CM, Kwon HJ, Yoo YD, Kim TW, Lee
YS, Lee SJ: Induction of cell cycle arrest and apoptosis in
human breast cancer cells by quercetin.  Int J Oncol 2001,
19:837-844.
12. Khanduja K, Gandhi R, Pathania V, Syal N: Prevention of N-
nitrosodiethylamine-induced lung tumorigenesis by ellagic
acid and quercetin in mice.  Food and Chem Toxicol 1999,
37:313-318.
13. Denda A, Endoh T, Tang Q, Tsujiuchi T, Nakae D, Konishi Y: Pre-
vention by inhibitors of arachidonic acid cascade of liver car-
cinogenesis, cirrhosis and oxidative DNA damage caused by
a choline-deficient, L-amino acid-defined diet in rats. Mutation
Res 1998, 402:279-288.
14. Scambia G: Quercetin enhances transforming growth factor
beta 1 secretion by human ovarian cancer cells. Int J Cancer
1994, 57:211-215.
15. Cook N, Samman S: Flavonoids-Chemistry, metabolism, cardi-
oprotective effects, and dietary sources. J Nutr Biochem 1996,
7:66-76.
16. Huber W, McDaniel L, Kaderlik K, Teitel C, Lang N, Kadlubar F: Che-
moprotection against the formation of colon DNA adducts
from the food-borne carcinogen 2-amino-1-methyl-6-phe-
nylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutation Res 1997,
376:115-122.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Nutrition Journal 2005, 4:11 http://www.nutritionj.com/content/4/1/11
Page 7 of 7
(page number not for citation purposes)
17. Yang CS, Landau JM, Huang MT, Newmark HL: Inhibition of car-
cinogenesis by dietary polyphenolic compounds. Annu Rev Nutr
2001, 21:381-406.
18. Grider A, Mouat MF: The acrodermatitis enteropathica muta-
tion affects protein expression in human fibroblasts: analysis
by two-dimensional gel electrophoresis.  J Nutr 1998,
128:1311-1314.
19. Friedman DB, Hill S, Keller JW, Merchant NB, Levy SE, Coffey RJ,
Caprioli RM: Proteome analysis of human colon cancer by
two-dimensional difference gel electrophoresis and mass
spectrometry. Proteomics 2004, 4:793-811.
20. Stulik J, Hernychova L, Porkertova S, Knizek J, Macela A, Bures J,
Jandik P, Langridge JI, Jungblut PR: Proteome study of colorectal
carcinogenesis. Electrophoresis 2001, 22:3019-3025.
21. Tsunoda T, Nakamura T, Ishimoto K, Yamaue H, Saijo N, Nishio K:
Upregulated expression of angiogenesis genes and down reg-
ulation of cell cycle genes in human colorectal cancer tissue
determined by cDNA macroarray.  Anticancer Res 2001,
21:137-143.
22. Gharib TG, Chen G, Wang H, Huang C-C, Prescott MS, Shedden K,
Misek DE, Thomas DG, Giordano TJ, Taylor JMG, Kardia S, Yee J,
Orringer MB, Hanash S, Beer DG: Proteomic analysis of cytoker-
atin isoforms uncovers association with survival in lung
adenocarcinoma. Neoplasia 2002, 4:440-448.
23. Raul U, Sawant S, Dange P, Kalraiya R, Ingle A, Vaidya M: Implica-
tions of cytokeratin 8/18 filament formation in stratified epi-
thelial cells: induction of transformed phenotype. Int J Cancer
2004, 111:662-668.
24. Casanova ML, Bravo A, Martinez-Palacio J, Fernandez-Acenero MJ,
Villanueva C, Larcher F, Conti CJ, Jorcano JL: Epidermal abnormal-
ities and increased malignancy of skin tumors in human epi-
dermal keratin 8-expressing transgenic mice. FASEB J 2004,
18:1556-1558.
25. Wenzel U, Herzog A, Kuntz S, Daniel H: Protein expression pro-
filing identifies molecular targets of quercetin as a major die-
tary flavonoid in human colon cancer cells. Proteomics 2004,
4:2160-2174.
26. Herzog A, Kuntz S, Daniel H, Wenzel U: Identification of biomar-
kers for the initiation of apoptosis in human preneoplastic
colonocytes by proteome analysis.  Int J Cancer 2004,
109:220-229.